TPM502

· Topas Therapeutics GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TPM502, covering 2025-12-03 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety of TPM502 in Adults With Celiac Disease [Phase 2]